A Decentralized, Status neutral, Stakeholder-engaged, post-incarceration intervention for people with and at risk for HIV
Project Number1R61DA060627-01
Contact PI/Project LeaderAKIYAMA, MATTHEW
Awardee OrganizationALBERT EINSTEIN COLLEGE OF MEDICINE
Description
Abstract Text
A. Abstract
One out of six people with HIV (PWH) in the U.S. are incarcerated annually; two-thirds of incarcerated persons meet
criteria for substance use disorder (SUD) and many more in carceral settings are at risk for HIV. Ending the U.S. HIV
epidemic hinges on linking and engaging criminal legal system-involved people with and at risk for HIV, especially those
with SUDs, to optimize ART and PrEP uptake and adherence. Carceral facilities can offer ART and PrEP access, and
increasingly SUD treatment, but in the year following release, nearly 80% of PWH lack viral suppression, and PrEP
coverage is extremely limited. Post-release disruptions in ART stem from multiple causes: health system complexity, SUD
relapse, unstable housing, medical mistrust, and stigma. PrEP outcomes are underexplored, but preliminary data suggest
similar challenges. Because HIV transmission risk is high upon community re-entry, multimodal interventions among
recently incarcerated people with and at risk for HIV are critical to ending the HIV epidemic. The goal of this phased
R61/R33 proposal is to develop a Decentralized, Status neutral, Stakeholder-engaged, post-incarceration intervention
for people with and at risk for HIV with SUD: The DEST2nation model. In addition to peer navigation, we will collaborate
with carceral-focused community-based organizations to address competing priorities, such as unstable housing, lack of
employment in culturally sensitive environments that mitigate stigma. Our specific aims are to: Aim 1 (R61 phase): Pilot
and refine a package of decentralized strategies to address barriers impacting criminal legal system-involved people with
HIV and those at risk. Aim 2: (R33 phase): Test the DEST2nation model (vs. SoC) in a multisite randomized control trial.
Aim 3 (R33): Estimate the cost of implementing and sustaining DEST2nation, and assess its economic value, relative to
SoC, from healthcare sector, state-policymaker, and societal perspectives.
Public Health Relevance Statement
Project Narrative
HIV and substance use disorders are highly prevalent among people involved with the criminal legal system and
multiple barriers complicate access to medical care in the period following incarceration. Interventions that address these
barriers are critical to ending the HIV epidemic. The goal of this proposal is to evaluate a comprehensive, person-centered
model of post-incarceration care for people with and at risk for HIV that uses peers with lived experience of incarceration
to assist with linkage and engagement in medical care and substance use disorder treatment, community based-
organization partnerships to meet unmet social needs, and decentralized medical care to address barriers to access.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAdherenceAttentionCaringCase ManagementClientClinicClinicalClinical ServicesCollaborationsCommunicationCommunitiesComplexContinuity of Patient CareCounselingDataDecentralizationElementsEmploymentEnsureEnvironmentEpidemicFaceFortuneFundingGoalsHIVHealth Care CostsHealth Care SectorHealth systemHybridsImprisonmentIndividualInterventionJailKnowledgeLegalLegal systemLinkLived experienceLocationLogicMedicalMental HealthModelingMotivationNew JerseyOutcomeParticipantPersonsPhasePhiladelphiaPilot ProjectsPolicy MakerPreparationProcessProductivityProviderQuality-Adjusted Life YearsRandomized, Controlled TrialsReach, Effectiveness, Adoption, Implementation, and MaintenanceRelapseResearchResourcesRiskServicesSiteSocial WorkSocietiesSubstance Use DisorderTelemedicineTestingText MessagingTimeViralarmcare deliverycare systemscommunity advisory boardcommunity organizationscommunity reentrycost effectivecost effective interventioncost estimateeconomic valueeffectiveness/implementation trialevidence baseexperiencehealth equity promotionhealth organizationhousing instabilityimplementation barriersimplementation protocolimplementation researchimplementation strategyimprovedimproved outcomeinnovationmembermulti-component interventionmulti-site trialmultimodalitypatient engagementpeerperson centeredpre-exposure prophylaxissafety netsocialsocial stigmastandard carestandard of carestemsuccesstransmission processtrustworthinessuptake
National Institute of Allergy and Infectious Diseases
$959,996
2024
National Institute on Drug Abuse
$3,234
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R61DA060627-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R61DA060627-01
Patents
No Patents information available for 1R61DA060627-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R61DA060627-01
Clinical Studies
No Clinical Studies information available for 1R61DA060627-01
News and More
Related News Releases
No news release information available for 1R61DA060627-01
History
No Historical information available for 1R61DA060627-01
Similar Projects
No Similar Projects information available for 1R61DA060627-01